Asclepius Bio-Tech is one of the most reliable and professional api manufacturers and suppliers in China. The Active Pharmaceutical Ingredient (API) is the part of any drug that produces its effects. Some drugs, such as combination therapies, have multiple active ingredients to treat different symptoms or act in different ways. If you are interested in our api, please be free to buy top quality, organic and natural products for sale from our factory. We will offer you the best service and fast delivery.
Pregabalin is an anticonvulsant drug used for neuropathic pain and as an adjunct therapy for partial seizures with or without secondary generalization in adults.It has also been found effective for generalized anxiety disorder and is (as of 2007) approved for this use in the...Read More
Nicotinamide Riboside is a natural ingredient that is found in milk. It is actually related to niacin and other forms of vitamin B3. This molecule has become more and more popular today because of various scientific studies that prove its ability to prevent obesity by helping...Read More
Vitamin B12, vitamin B12 or vitamin B-12, also called cobalamin, is a water- soluble vitamin with a key role
in the normal functioning of the brain and nervous system, and for the formation of blood.Read More
Melatonin is a hormone made by the pineal gland, a small gland in the brain. Melatonin helps control your sleep and wake cycles. Very small amounts of it are found in foods such as meats, grains, fruits, and vegetables. Your body has its own internal clock that controls your...Read More
Andarine (S-4) is one of SARMS in the market. Like all SARMs, Andarine is a selective androgen receptor modulator. It’s full name is S-40503, and it quickly became known as S-4, while stronger versions have been dubbed Andarine. Andarine was developed by the Japanese...Read More
GW501516 (also known as GW-501,516, GW1516, GSK-516 and on the black market as Endurobol) is a PPAR receptor agonist that was invented in a collaboration between Ligand Pharmaceuticals and GlaxoSmithKline in the 1990s, was entered into clinical development as a drug candidate...Read More